Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAge Labs (BIOA) Long-Term Debt Repayments (2024 - 2025)

BioAge Labs (BIOA) has disclosed Long-Term Debt Repayments for 2 consecutive years, with $1.5 million as the latest value for Q4 2025.

  • Quarterly Long-Term Debt Repayments changed 0.0% to $1.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6.0 million through Dec 2025, changed 0.0% year-over-year, with the annual reading at $6.0 million for FY2025, 0.0% changed from the prior year.
  • Long-Term Debt Repayments hit $1.5 million in Q4 2025 for BioAge Labs, roughly flat from $1.5 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.5 million in Q1 2024 to a low of $1.5 million in Q1 2024.